© Copyright 2025 American Medical Association. All rights reserved.
| Short Descr | ADM SARSCOV2 30MCG/0.3ML 1ST | Medium Descr | IMM ADMN SARSCOV2 30MCG/0.3ML DIL RECON 1ST DOSE | Long Descr | Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, diluent reconstituted; first dose | Status Code | Not Valid for Medicare Purposes | Global Days | XXX - Global Concept Does Not Apply | PC/TC Indicator (26, TC) | 9 - Not Applicable | Multiple Procedures (51) | 9 - Concept does not apply. | Bilateral Surgery (50) | 9 - Concept does not apply. | Physician Supervisions | 09 - Concept does not apply. | Assistant Surgeon (80, 82) | 9 - Concept does not apply. | Co-Surgeons (62) | 9 - Concept does not apply. | Team Surgery (66) | 9 - Concept does not apply. | Diagnostic Imaging Family | 99 - Concept Does Not Apply | APC Status Indicator | Non-Covered Service, not paid under OPPS | Berenson-Eggers TOS (BETOS) | none | MUE | Not applicable/unspecified. |
| CS | Cost-sharing waived for specified covid-19 testing-related services that result in and order for or administration of a covid-19 test and/or used for cost-sharing waived preventive services furnished via telehealth in rural health clinics and federally qualified health centers during the covid-19 public health emergency | 59 | Distinct procedural service: under certain circumstances, it may be necessary to indicate that a procedure or service was distinct or independent from other non-e/m services performed on the same day. modifier 59 is used to identify procedures/services, other than e/m services, that are not normally reported together, but are appropriate under the circumstances. documentation must support a different session, different procedure or surgery, different site or organ system, separate incision/excision, separate lesion, or separate injury (or area of injury in extensive injuries) not ordinarily encountered or performed on the same day by the same individual. however, when another already established modifier is appropriate it should be used rather than modifier 59. only if no more descriptive modifier is available, and the use of modifier 59 best explains the circumstances, should modifier 59 be used. note: modifier 59 should not be appended to an e/m service. to report a separate and distinct e/m service with a non-e/m service performed on the same date, see modifier 25. | 95 | Synchronous telemedicine service rendered via a real-time interactive audio and video telecommunications system: synchronous telemedicine service is defined as a real-time interaction between a physician or other qualified health care professional and a patient who is located at a distant site from the physician or other qualified health care professional. the totality of the communication of information exchanged between the physician or other qualified health care professional and the patient during the course of the synchronous telemedicine service must be of an amount and nature that would be sufficient to meet the key components and/or requirements of the same service when rendered via a face-to-face interaction. modifier 95 may only be appended to the services listed in appendix p. appendix p is the list of cpt codes for services that are typically performed face-to-face, but may be rendered via a real-time (synchronous) interactive audio and video telecommunications system. | GW | Service not related to the hospice patient's terminal condition |
|
Date
|
Action
|
Notes
|
|---|---|---|
| 2025-01-01 | Deleted | First appearance of code deletion in codebook. |
| 2025-01-01 | Note | First appearance of code deletion in codebook. |
| 2023-11-01 | Deleted | Code deleted. To report administration of COVID-19 vaccine, use 90480. |
| 2023-05-01 | Note | Changes made to dosing information. |
| 2023-04-18 | Note | These codes (previously associated with 0001A) are no longer authorized for use in the United States: 91300, 91305, 91307, 91308. |
| 2023-04-18 | Note | No longer authorized for use in the United States. |
| 2023-01-01 | Note | AMA guideline changed to include 91308 effective upon receiving Emergency Use Authorization or approval from the FDA |
| 2022-12-08 | Note | AMA guideline changed to include 91317. Published to website 2021-12-09. Received FDA approval effective retroactively to 2022-12-08. |
| 2022-10-12 | Note | AMA Guideline changed. 91315 received FDA approval. |
| 2022-08-31 | Note | Changes made to vaccine name, product & dosing information, & patient age to (12+). |
| 2022-08-31 | Note | AMA guideline changed to include 91312, 91315 effective upon receiving Emergency Use Authorization or approval from the FDA |
| 2022-08-31 | Note | AMA Guideline changed. 91312 received FDA approval effective immediately. |
| 2022-06-17 | Note | AMA Guideline changed. 91308 received FDA approval. |
| 2022-02-01 | Note | AMA guideline changed to include 91308 effective upon receiving Emergency Use Authorization or approval from the FDA |
| 2022-01-01 | Note | First appearance of 2020-2021 AMA guideline changes in codebook. |
| 2022-01-01 | Note | Grammar correction |
| 2022-01-01 | Changed | Code description changed. |
| 2022-01-01 | Added | First appearance in codebook. |
| 2021-10-29 | Note | AMA Guideline changed. 91305, 91307 received FDA approval. |
| 2021-10-06 | Note | AMA guideline changed to include 91307 effective upon receiving Emergency Use Authorization or approval from the FDA |
| 2021-09-22 | Note | AMA Guideline changed. 0004A received FDA approval. |
| 2021-09-03 | Note | AMA guideline changed to include 0004A, 91305 effective upon receiving Emergency Use Authorization or approval from the FDA |
| 2021-09-03 | Note | AMA guidelines added to include 0002A, 0003A, 91300. These codes were published to AMA website and received FDA approval prior to addition of the guideline. |
| 2021-01-01 | Added | First appearance of code in CPT® Code Set. |
| 2020-12-11 | Added | FDA approval received. |
| 2020-11-10 | Added | Published on AMA website. Effective upon receiving emergency Use Authorization or approval from the FDA. |
Get instant expert-level medical coding assistance.